M
Marc H Hemmelder
Researcher at Maastricht University
Publications - 85
Citations - 2969
Marc H Hemmelder is an academic researcher from Maastricht University. The author has contributed to research in topics: Medicine & Dialysis. The author has an hindex of 19, co-authored 55 publications receiving 1902 citations. Previous affiliations of Marc H Hemmelder include Maastricht University Medical Centre.
Papers
More filters
Journal ArticleDOI
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.
Kitty J Jager,Anneke Kramer,Nicholas C. Chesnaye,Cécile Couchoud,J. Emilio Sánchez-Álvarez,Liliana Garneata,Frederic Collart,Marc H Hemmelder,Patrice M. Ambühl,Julia Kerschbaum,Camille Legeai,María Dolores del Pino y Pino,Gabriel Mircescu,Lionel Mazzoleni,Tiny Hoekstra,Rebecca Winzeler,Gert Mayer,Vianda S. Stel,Christoph Wanner,Carmine Zoccali,Ziad A. Massy +20 more
TL;DR: The pandemic has had a substantial effect on mortality in patients receiving kidney replacement therapy; a highly vulnerable population due to underlying chronic kidney disease and high prevalence of multimorbidity.
Journal ArticleDOI
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration.
Luuk B. Hilbrands,Raphaël Duivenvoorden,Priya Vart,Priya Vart,Casper F. M. Franssen,Marc H Hemmelder,Kitty J Jager,Lyanne M. Kieneker,Marlies Noordzij,Michelle J Pena,Hanne de Vries,David Arroyo,Adrian Covic,Marta Crespo,Eric Goffin,Mahmud Islam,Ziad A. Massy,Ziad A. Massy,Nuria Montero,João Pedro Oliveira,Ana Roca Muñoz,J Emilio Sanchez,Sivakumar Sridharan,Rebecca Winzeler,Ron T. Gansevoort +24 more
TL;DR: The 28-day case-fatality rate is high in patients on kidney replacement therapy with COVID-19 and is primarily driven by the risk factors age and frailty.
Journal ArticleDOI
Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.
TL;DR: A significantly greater antiproteinuric effect of 'non-ACEI' antihypertensives was found in diabetic patients compared to non-diabetics, and this coincided with a greater blood pressure reduction in diabetics.
Journal ArticleDOI
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
Maartje C. J. Slagman,Femke Waanders,Marc H Hemmelder,Arend-Jan Woittiez,Wilbert M.T. Janssen,Hiddo J.L. Heerspink,Gerjan Navis,Gozewijn D. Laverman +7 more
TL;DR: Dietary sodium restriction to a level recommended in guidelines was more effective than dual blockade for reduction of proteinuria and blood pressure in non-diabetic nephropathy and support the combined endeavours of patients and health professionals to reduce sodium intake.
Journal ArticleDOI
The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary.
Anneke Kramer,Maria Pippias,Marlies Noordzij,Vianda S. Stel,Anton M. Andrusev,Manuel I Aparicio-Madre,Federico E Arribas Monzón,Anders Åsberg,Myftar Barbullushi,Palma Beltrán,Marjolein Bonthuis,Fergus Caskey,Fergus Caskey,Pablo Castro de la Nuez,Harijs Cernevskis,Johan De Meester,Patrik Finne,Eliezer Golan,James G. Heaf,Marc H Hemmelder,Kyriakos Ioannou,Nino Kantaria,Kirill Komissarov,Grzegorz Korejwo,Reinhard Kramar,Mathilde Lassalle,Frantisek Lopot,Fernando Macário,Bruce Mackinnon,Runolfur Palsson,Runolfur Palsson,Ülle Pechter,Vicente Celestino Piñera,Carmen Santiuste de Pablos,Alfons Segarra-Medrano,Nurhan Seyahi,Maria Fernanda Slon Roblero,Olivera Stojceva-Taneva,Evgueniy Vazelov,Rebecca Winzeler,Edita Ziginskiene,Ziad A. Massy,Kitty J Jager +42 more
TL;DR: The epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2016 within 36 countries was described, with the incidence and prevalence higher among men than women, and men had a higher rate of kidney transplantation compared with women.